AI steps into the Doctor's office to catch hidden liver damage
NCT ID NCT07305324
Summary
This study is testing a new AI tool called FibroX to see if it helps primary care doctors more accurately diagnose advanced liver scarring in patients with fatty liver disease. Doctors will review simulated patient cases, using either their usual methods or the AI tool, to see which approach leads to better decisions. The goal is to see if this technology can be easily used in everyday clinics to catch serious liver problems earlier.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASLD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.